<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comentários em: CE aprova avelumab para tratamento de manutenção do carcinoma urotelial	</title>
	<atom:link href="https://newsfarma.pt/noticias/ce-aprova-avelumab-para-tratamento-de-manutencao-do-carcinoma-urotelial/feed/" rel="self" type="application/rss+xml" />
	<link>https://newsfarma.pt/noticias/ce-aprova-avelumab-para-tratamento-de-manutencao-do-carcinoma-urotelial/</link>
	<description>Comunicamos Saúde.</description>
	<lastBuildDate>Wed, 03 Feb 2021 15:51:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
</channel>
</rss>
